CClinicalTrials.gg
RecruitingNCT03180905Updated Sep 29, 2023

ImPACT Normative Extension

An interventional study of ImPACT Online/Paper Pencil Tests and ImPACT Online in Brain Concussion, sponsored by ImPACT Applications, Inc.. Recruiting at 3 sites in United States. Open to participants aged 60 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-29.

Sponsored by ImPACT Applications, Inc. · Not applicable, Interventional, and Screening

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 9 months ago, but the record still lists the study as recruiting.
  • Started May 2017; still recruiting 9 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
800
Allocation
Non-randomized
Ages
60 Years to 80 Years
Sex
All
01

Study summary

The researchers want to find out more about a standalone software application, ImPACT Online and how it relates to other commonly used tests of memory, attention and reaction time. ImPACT Online is a computer-based neurocognitive test for concussion management. The test was designed to help measure the effects of concussion on cognitive processes (for example, memory, attention, brain speed) and visual functioning.

02

Conditions studied

  • Brain Concussion

Browse trials for

03

In context

Brain Concussion

530 studies on the registry are indexed under Brain Concussion; 151 are open to participants now.

This study's planned enrollment of 800 is above the median of 64 across 364 interventional studies indexed under Brain Concussion.

Browse Brain Concussion studies →

Lead sponsor

ImPACT Applications, Inc. is the lead sponsor of 4 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Age: 60-80
  2. Primary English speaking or fluent in English.
  3. Currently does not reside in a skilled nursing facility.
  4. Currently not suffering from a concussion or being treated for a concussion, unless enrolled in the subgroup Discriminative Validity.
  5. No known physical, neurological, behavioral or psychological impairment that would affect their ability to perform the test.
  6. Hearing or vision impairments that have not been corrected within normal limits.
  7. A score of 24 or greater on the MMSE (Mini-Mental State Examination).

Exclusion criteria

Exclusion Criteria:

  1. English is not their primary language nor are they proficient in the English language.
  2. Currently resides in a skilled nursing facility.
  3. Currently suffering from a concussion or being treated for a concussion, unless enrolled in the subgroup Discriminative Validity.
  4. Known physical, neurological, behavioral, or psychological impairment that would affect their ability to take or complete the test.
  5. Hearing or vision impairments that would affect their ability to perform the test.
  6. Score of 23 or below on the MMSE(Mini-Mental State Examination).
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
800 participants (estimated)

Study arms

  • Experimental
    Validity

    ImPACT Online a computerized test will be administered to subjects. They will also receive a battery of paper and pencil neuropsychological tests.

    Device: ImPACT Online/Paper Pencil Tests

  • Active comparator
    Test/Re-Test

    ImPACT Online will be administered at 2 time points

    Device: ImPACT Online

Interventions

  • DeviceImPACT Online/Paper Pencil Tests

    Compare ImPACT Online versus Paper and Pencil Neurocognitive Tests

  • DeviceImPACT Online

    ImPACT Online will be administered at 2 time points.

06

What researchers measure

Primary outcomes

  1. Validity

    ImPACT Online compared to Brief Visuospatial Memory Test

    Time frame: 12 Months

  2. Validity

    ImPACT Online compared to Symbol Digit Modalities Test

    Time frame: 12 Months

  3. Validity

    ImPACT Online compared to Color Trails

    Time frame: 12 Months

  4. Validity

    ImPACT Online compared to Hopkins Verbal Learning Test.

    Time frame: 12 Months

Secondary outcomes

  1. Reliability

    Reliability will be established through a test/re-test. Online ImPACT will be administered at 2 time points to establish results should be stable over time.

    Time frame: Baseline Test will be administered at enrollment and re- test will be administered within 30 days of baseline test.

07

Study locations

1 of 3 sites recruiting
  • Comprehensive Med Psych Systems, Inc.
    Sarasota, Florida 34236, United States
    Completed
  • University of Albany
    Albany, New York 12222, United States
    Completed
  • ImPACT Applications Inc.
    Pittsburgh, Pennsylvania 15228, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 29, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03180905
Lead sponsor
ImPACT Applications, Inc.
Responsible party
Sponsor
First posted
Jun 8, 2017
Start date
May 1, 2017
Primary completion
Dec 31, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
Sep 29, 2023

Study contacts

Jane Luce
Contact
jluce@impacttest.com
412-567-8400 ext. 938

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion